Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

metformin (Diabex)

Tablets, Oral, 500 mg, Once daily, single dose

DRUG

metformin (Glucophage™)

Tablets, Oral, 500 mg, Once Daily, single dose

DRUG

metformin (Glucophage™)

Tablets, Oral, 1000 mg, Once daily, single dose

DRUG

metformin (Diabex)

Tablets, Oral, 1000 mg, Once daily, single dose

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY